212 related articles for article (PubMed ID: 12189383)
1. Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.
Yee C; Greenberg P
Nat Rev Cancer; 2002 Jun; 2(6):409-19. PubMed ID: 12189383
[No Abstract] [Full Text] [Related]
2. Cancer immunotherapy: a treatment for the masses.
Blattman JN; Greenberg PD
Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
[TBL] [Abstract][Full Text] [Related]
3. Natural T cell immunity against cancer.
Nagorsen D; Scheibenbogen C; Marincola FM; Letsch A; Keilholz U
Clin Cancer Res; 2003 Oct; 9(12):4296-303. PubMed ID: 14555498
[TBL] [Abstract][Full Text] [Related]
4. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
5. An introduction to tumour immunology.
Keith J
Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
[No Abstract] [Full Text] [Related]
6. Monitoring cellular immune responses to cancer immunotherapy.
Morse MA; Clay TM; Hobeika AC; Mosca PJ; Lyerly HK
Curr Opin Mol Ther; 2001 Feb; 3(1):45-52. PubMed ID: 11249731
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
8. An introduction to tumour immunology.
James K
Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
[TBL] [Abstract][Full Text] [Related]
9. Advances in specific immunotherapy for prostate cancer.
Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
[TBL] [Abstract][Full Text] [Related]
10. [Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring].
Chouaib S; Echchakir H; Angevin E; Guerra N; Kosmatopoulos K; Caignard A; Lim A; Baron V; Ferradini L; Mami-Chouaib F
Bull Cancer; 2001 Aug; 88(8):733-40. PubMed ID: 11578941
[TBL] [Abstract][Full Text] [Related]
11. Regulatory T cells, tumour immunity and immunotherapy.
Zou W
Nat Rev Immunol; 2006 Apr; 6(4):295-307. PubMed ID: 16557261
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of immunity in cancer.
Baldwin RW
Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216
[No Abstract] [Full Text] [Related]
13. Escape mechanisms in tumor immunity: an update.
Müller L; Kiessling R; Rees RC; Pawelec G
J Environ Pathol Toxicol Oncol; 2002; 21(4):277-330. PubMed ID: 12510961
[TBL] [Abstract][Full Text] [Related]
14. The immunotherapy of prostate and bladder cancer.
Totterman TH; Loskog A; Essand M
BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic lymphoma vaccines: importance of T-cell immunity.
Neelapu SS; Lee ST; Qin H; Cha SC; Woo AF; Kwak LW
Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
[TBL] [Abstract][Full Text] [Related]
16. Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy.
Peggs KS; Quezada SA; Allison JP
Immunol Rev; 2008 Aug; 224():141-65. PubMed ID: 18759925
[TBL] [Abstract][Full Text] [Related]
17. Promises and limitations of murine models in the development of anticancer T-cell vaccines.
Lévy F; Colombetti S
Int Rev Immunol; 2006; 25(5-6):269-95. PubMed ID: 17169777
[TBL] [Abstract][Full Text] [Related]
18. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
19. Cancer immunotherapy.
Falk RE
Can Med Assoc J; 1979 Feb; 120(3):255, 258. PubMed ID: 311678
[No Abstract] [Full Text] [Related]
20. Tumor immunology.
Herberman RB
JAMA; 1992 Nov; 268(20):2935-9. PubMed ID: 1433711
[No Abstract] [Full Text] [Related]
[Next] [New Search]
